Pitressin 20 PU/ml Solution for Injection Irlande - anglais - HPRA (Health Products Regulatory Authority)

pitressin 20 pu/ml solution for injection

mercury pharmaceuticals ltd - argipressin - solution for injection - 20 unit(s)/millilitre - vasopressin and analogues; argipressin

Jinarc Union européenne - anglais - EMA (European Medicines Agency)

jinarc

otsuka pharmaceutical netherlands b.v. - tolvaptan - polycystic kidney, autosomal dominant - diuretics, - jinarc is indicated to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (adpkd) in adults with ckd stage 1 to 3 at initiation of treatment with evidence of rapidly progressing disease.

Samsca Union européenne - anglais - EMA (European Medicines Agency)

samsca

otsuka pharmaceutical netherlands b.v. - tolvaptan - inappropriate adh syndrome - diuretics, - treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (siadh).,

Tolvaptan Accord Union européenne - anglais - EMA (European Medicines Agency)

tolvaptan accord

accord healthcare s.l.u. - tolvaptan - inappropriate adh syndrome - diuretics, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).

Neo-Lidocaton Nouvelle-Zélande - anglais - Medsafe (Medicines Safety Authority)

neo-lidocaton

*** company unknown *** - lidocaine hydrochloride monohydrate 20mg; noradrenaline 0.02mg; vasopressin 0.25 [iu] - solution for injection - 2 % - active: lidocaine hydrochloride monohydrate 20mg noradrenaline 0.02mg vasopressin 0.25 [iu]

Desmospray, Desmopressin Nasal Spray Irlande - anglais - HPRA (Health Products Regulatory Authority)

desmospray, desmopressin nasal spray

ferring ireland ltd - desmopressin acetate - nasal spray, solution - 10 microgram(s) - vasopressin and analogues; desmopressin